Skip to main content
Erschienen in: Pediatric Nephrology 5/2009

01.05.2009 | Brief Report

Renal dysplasia/hypoplasia, Williams Syndrome phenotype and non-Hodgkin lymphoma in the same patient: only a coincidence?

verfasst von: Adela Urisarri-Ruiz de Cortázar, Marta Gil Calvo, Manuel Vázquez Donsión, Gema Ariceta Iraola, Jose Miguel Couselo Sánchez

Erschienen in: Pediatric Nephrology | Ausgabe 5/2009

Einloggen, um Zugang zu erhalten

Abstract

Congenital renal anomalies, Williams Syndrome and non-Hodgkin lymphoma all occur separately at low incidence, so their simultaneous presence in the same patient is exceptional. We present a young patient manifesting all three conditions. This child is a boy with a Williams Syndrome phenotype who was diagnosed with severe chronic kidney disease secondary to bilateral renal dysplasia/hypoplasia. Due to his small size, he received treatment with growth hormone. He progressed to end stage kidney disease and, after 8 months, a renal transplant was performed. A number of suspicious abdominal adenopathies were removed during the surgery and, thereafter, immunosupressive treatment with prednisone, azathioprine and cyclosporine was initiated. Examination of the biopsy tissue confirmed the presence of a T-cell lymphoblastic lymphoma. Appropriate chemotherapy was given, and the immunosupressive regimen was eventually reduced to prednisone alone. Now, 8 years since the initial diagnosis of T-cell lymphoblastic lymphoma and 6 years after the completion of the chemotherapy, the patient is still in complete remission with a functional donor kidney. We discuss some possible explanations of this association. Chemotherapy has not appeared to have affected the viability of the grafted kidney and, in fact, it may even have induced immunotolerance.
Literatur
1.
Zurück zum Zitat Pope JC 4th, Brock JW 3rd, Adams MC, Stephens FD, Ichikawa I (1999) How the begin and how the end: classic and new theories for the development and deterioration of congenital anomalies of the kidney and urinary tract, CAKUT. J Am Soc Nephrol 10:2018–2028PubMed Pope JC 4th, Brock JW 3rd, Adams MC, Stephens FD, Ichikawa I (1999) How the begin and how the end: classic and new theories for the development and deterioration of congenital anomalies of the kidney and urinary tract, CAKUT. J Am Soc Nephrol 10:2018–2028PubMed
2.
Zurück zum Zitat Seikaly MG, Ho PL, Emmett L, Fine RN, Tejani A (2003) Chronic renal insufficiency in children: the 2001 Annual Report of NAPRTCS. Pediatr Nephrol 18:796–804CrossRef Seikaly MG, Ho PL, Emmett L, Fine RN, Tejani A (2003) Chronic renal insufficiency in children: the 2001 Annual Report of NAPRTCS. Pediatr Nephrol 18:796–804CrossRef
3.
Zurück zum Zitat Committee on Genetics (2001) American Academy of Pediatrics: health care supervision for children with Williams Syndrome. Pediatrics 107:1192–1204 Committee on Genetics (2001) American Academy of Pediatrics: health care supervision for children with Williams Syndrome. Pediatrics 107:1192–1204
4.
Zurück zum Zitat Ewart AK, Morris CA, Atkinson D, Jim W, Sternes K, Spallone P, Stock AD, Leppert M, Keating MT (1993) Hemizygosity at the elastin locus in a developmental disorder, Williams Syndrome. Nat Genet 5:11–16CrossRef Ewart AK, Morris CA, Atkinson D, Jim W, Sternes K, Spallone P, Stock AD, Leppert M, Keating MT (1993) Hemizygosity at the elastin locus in a developmental disorder, Williams Syndrome. Nat Genet 5:11–16CrossRef
5.
Zurück zum Zitat Nathan DG, Orkin SH, Look T (2003) Nathan & Oski’s hematology of infancy and childhood, 6th edn. Saunders, Philadelphia Nathan DG, Orkin SH, Look T (2003) Nathan & Oski’s hematology of infancy and childhood, 6th edn. Saunders, Philadelphia
6.
Zurück zum Zitat Sanna-Cherchi S, Caridi G, Weng PL, Scolari F, Perfumo F, Charavi AG, Ghiggeri GM (2007) Genetic approaches to human renal agenesis/hypoplasia and dysplasia. Pediatr Nephrol 22:1675–1684CrossRef Sanna-Cherchi S, Caridi G, Weng PL, Scolari F, Perfumo F, Charavi AG, Ghiggeri GM (2007) Genetic approaches to human renal agenesis/hypoplasia and dysplasia. Pediatr Nephrol 22:1675–1684CrossRef
7.
Zurück zum Zitat Schedl A (2007) Renal abnormalities and their developmental origin. Nat Rev Genet 8:791–802CrossRef Schedl A (2007) Renal abnormalities and their developmental origin. Nat Rev Genet 8:791–802CrossRef
8.
Zurück zum Zitat Tassabehji M (2003) Williams–Beuren syndrome: a challenge for genotype–phenotype correlations. Hum Mol Genet 12:R229–R237CrossRef Tassabehji M (2003) Williams–Beuren syndrome: a challenge for genotype–phenotype correlations. Hum Mol Genet 12:R229–R237CrossRef
9.
Zurück zum Zitat Guo XL, Pan L, Zhang XJ, Suo XH, Niu ZY, Zhang JY, Wang F, Dong ZR, Da W, Ohno R (2007) Expression and mutation analysis of genes that encodes the Myc antagonist Mad1, Mxi1 and Rox in acute leukaemia. Leuk Lymphoma 48:1200–1207CrossRef Guo XL, Pan L, Zhang XJ, Suo XH, Niu ZY, Zhang JY, Wang F, Dong ZR, Da W, Ohno R (2007) Expression and mutation analysis of genes that encodes the Myc antagonist Mad1, Mxi1 and Rox in acute leukaemia. Leuk Lymphoma 48:1200–1207CrossRef
10.
Zurück zum Zitat Dean HJ, Kellet JG, Bala RM, Guyda HJ, Bhaumick B, Posner BI, Friesen HG (1982) The effect of growth hormone treatment on somatomedin levels in growth hormone deficient children. J Clin Endocrinol Metab 55:1167–1173CrossRef Dean HJ, Kellet JG, Bala RM, Guyda HJ, Bhaumick B, Posner BI, Friesen HG (1982) The effect of growth hormone treatment on somatomedin levels in growth hormone deficient children. J Clin Endocrinol Metab 55:1167–1173CrossRef
11.
Zurück zum Zitat Ghigo E, Aimaretti G, Maccario M, Fanciulli G, Arvat E, Minuto F, Giordano G, Delitala G, Camanni F (1999) Dose-response study of GF effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women. Am J Physiol 276:E1009–E1013PubMed Ghigo E, Aimaretti G, Maccario M, Fanciulli G, Arvat E, Minuto F, Giordano G, Delitala G, Camanni F (1999) Dose-response study of GF effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women. Am J Physiol 276:E1009–E1013PubMed
12.
Zurück zum Zitat Cohen P, Clemmons DR, Rosenfeld RG (2000) Does the GH-IGF axis play a role in cancer pathogenenesis? Growth Horm IGF Res 10:297–305CrossRef Cohen P, Clemmons DR, Rosenfeld RG (2000) Does the GH-IGF axis play a role in cancer pathogenenesis? Growth Horm IGF Res 10:297–305CrossRef
13.
Zurück zum Zitat Swerdlow AJ, Higgins CD, Adlard P, Preece MA (2002) Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959–85: a cohort study. Lancet 360:273–277CrossRef Swerdlow AJ, Higgins CD, Adlard P, Preece MA (2002) Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959–85: a cohort study. Lancet 360:273–277CrossRef
14.
Zurück zum Zitat Abs R, Bengtsson BA, Hernberg-Stahl E, Monson JP, Tauber JP, Wilton P, Wüster C (1999) GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clin Endocrinol 50:703–713CrossRef Abs R, Bengtsson BA, Hernberg-Stahl E, Monson JP, Tauber JP, Wilton P, Wüster C (1999) GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clin Endocrinol 50:703–713CrossRef
15.
Zurück zum Zitat El Cheik J, de Colella JM, Vacher-Copponat H, Moal V, Costello RT (2006) Non-Hodgkin’s lymphoma after kidney transplantation: a single institution study. Leuk Res 30:118–119CrossRef El Cheik J, de Colella JM, Vacher-Copponat H, Moal V, Costello RT (2006) Non-Hodgkin’s lymphoma after kidney transplantation: a single institution study. Leuk Res 30:118–119CrossRef
16.
Zurück zum Zitat Rubio-Viqueira B, Hidalgo M (2006) Targeting mTOR for cancer treatment. Curr Opin Investig Drugs 7:501–512PubMed Rubio-Viqueira B, Hidalgo M (2006) Targeting mTOR for cancer treatment. Curr Opin Investig Drugs 7:501–512PubMed
Metadaten
Titel
Renal dysplasia/hypoplasia, Williams Syndrome phenotype and non-Hodgkin lymphoma in the same patient: only a coincidence?
verfasst von
Adela Urisarri-Ruiz de Cortázar
Marta Gil Calvo
Manuel Vázquez Donsión
Gema Ariceta Iraola
Jose Miguel Couselo Sánchez
Publikationsdatum
01.05.2009
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 5/2009
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-008-1069-6

Weitere Artikel der Ausgabe 5/2009

Pediatric Nephrology 5/2009 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Häufigste Gründe für Brustschmerzen bei Kindern

06.05.2024 Pädiatrische Diagnostik Nachrichten

Akute Brustschmerzen sind ein Alarmsymptom par exellence, schließlich sind manche Auslöser lebensbedrohlich. Auch Kinder klagen oft über Schmerzen in der Brust. Ein Studienteam ist den Ursachen nachgegangen.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärztinnen und Psychotherapeuten.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.